Clinical trial
The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
NCT00436059 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
- Lead sponsor
- Vejle Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- July 31, 2009
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.